Tepel M, Heidenreich S, Zhu Z, Walter M, Nofer J R, Zidek W
Medizinische Poliklinik, University of Münster, Germany.
Kidney Int. 1994 Sep;46(3):696-702. doi: 10.1038/ki.1994.323.
To evaluate the underlying mechanism of the putative renal protective effects of angiotensin converting enzyme (ACE) inhibitors, the modulatory action of captopril on the angiotensin II (Ang II) and platelet-derived growth factor (PDGF)-induced increase of cytosolic free calcium concentration ([Ca2+]i) was investigated in cultured glomerular mesangial cells (MC) from spontaneously hypertensive rats from the Münster strain (SHR) and normotensive Wistar-Kyoto rats (WKY). Resting [Ca2+]i was not affected by captopril in MC from either SHR or WKY. Captopril inhibited the Ang II-induced [Ca2+]i increase in MC from both SHR and WKY in a dose-dependent and time-dependent fashion. The preincubation of MC with 1 mumol/liter captopril for 40 minutes significantly reduced the Ang II-induced [Ca2+]i increase in SHR from 167 +/- 30 nmol/liter (N = 17) to 74 +/- 20 nmol/liter (N = 8, P < 0.05) and in WKY from 102 +/- 42 nmol/liter (N = 14) to 43 +/- 12 nmol/liter (N = 7, P < 0.05). After removal of external calcium there was no significant effect of captopril on the Ang II-induced [Ca2+]i increase. With the Mn2+ quenching technique, it was confirmed that captopril affects Ca2+ influx. Phospholipase C activity as estimated by diacylglycerol formation was not changed by captopril. The preincubation of MC with 1 mumol/liter captopril for 40 minutes significantly reduced the PDGF-induced [Ca2+]i increase in SHR from 166 +/-54 nmol/liter (N = 9) to 31 +/- 19 nmol/liter (N = 6, P < 0.01) and in WKY from 127 +/- 31 nmol/liter (N = 11) to 61 +/- 32 nmol/liter (N = 5, P < 0.05). Similarly captopril reduced the [Ca2+]i increase induced by endothelin and vasopressin. The results indicate that the actions of Ang II and PDGF on MC are modulated by captopril, probably resulting in the impairment of the calcium dependent contractile response of mesangial cells.
为评估血管紧张素转换酶(ACE)抑制剂假定的肾脏保护作用的潜在机制,研究了卡托普利对来自明斯特品系自发性高血压大鼠(SHR)和正常血压的Wistar-Kyoto大鼠(WKY)的培养肾小球系膜细胞(MC)中血管紧张素II(Ang II)和血小板衍生生长因子(PDGF)诱导的胞质游离钙浓度([Ca2+]i)升高的调节作用。SHR和WKY的MC中的静息[Ca2+]i不受卡托普利影响。卡托普利以剂量依赖性和时间依赖性方式抑制SHR和WKY的MC中Ang II诱导的[Ca2+]i升高。将MC与1 μmol/升卡托普利预孵育40分钟,可使SHR中Ang II诱导的[Ca2+]i升高从167±30 nmol/升(N = 17)显著降低至74±20 nmol/升(N = 8,P < 0.05),使WKY中从102±42 nmol/升(N = 14)降低至43±12 nmol/升(N = 7,P < 0.05)。去除细胞外钙后,卡托普利对Ang II诱导的[Ca2+]i升高无显著影响。采用Mn2+淬灭技术证实卡托普利影响Ca2+内流。通过二酰基甘油形成估算的磷脂酶C活性不受卡托普利影响。将MC与1 μmol/升卡托普利预孵育40分钟,可使SHR中PDGF诱导的[Ca2+]i升高从166±54 nmol/升(N = 9)显著降低至31±19 nmol/升(N = 6,P < 0.01),使WKY中从127±31 nmol/升(N = 11)降低至61±32 nmol/升(N = 5,P < 0.05)。同样,卡托普利降低了内皮素和血管加压素诱导的[Ca2+]i升高。结果表明,卡托普利调节Ang II和PDGF对MC的作用,可能导致系膜细胞钙依赖性收缩反应受损。